William Blair has initiated coverage of Zimmer Biomet Holdings (ZBH) with a Market Perform rating. This announcement is amidst several recent analyst adjustments to price targets and ratings for the medical equipment company, following its Q4 2025 earnings call where it beat quarterly estimates on strong implant demand.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
William Blair Initiates Zimmer Biomet Holdings at Market Perform
William Blair has initiated coverage of Zimmer Biomet Holdings (ZBH) with a Market Perform rating. This announcement is amidst several recent analyst adjustments to price targets and ratings for the medical equipment company, following its Q4 2025 earnings call where it beat quarterly estimates on strong implant demand.